article thumbnail

STAT+: Behind CVS CEO’s ouster, a question: Do a pharmacy and a health insurer make sense together?

STAT

Does it make sense for a chain of drug stores to own a major health insurance company? That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer Aetna. had already been moving beyond retail since its 2007 deal for pharmacy benefit manager Caremark.

Insurance 130
article thumbnail

STAT+: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

STAT

And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out. “The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007.

Insurance 143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gilead pays $97m to resolve US illegal kickback claims

pharmaphorum

The charges relate to a period from 2007 until the end of 2010, when the Department of Justice alleges California-based Gilead routinely obtained data from the foundation detailing how much the foundation had spent for patients on Letairis. Gilead does not believe it violated the law and had no intention of doing so.

article thumbnail

Teva shares slide as it faces illegal kickback charges from US government

pharmaphorum

The US government alleges that the payments occurred from 2007 until the end of 2015, to charities called The Assistance Fund (TAF) and Chronic Disease Fund (CDF). Only this week the state of New York accused Teva and Allergan of insurance fraud for downplaying the risks of their opioid painkillers to patients and doctors.

article thumbnail

Why the drug pricing debate is focused on insulin

pharmaphorum

The cost of medical treatment of diabetes is now at the centre of a debate in US politics, as the House of Representatives recently voted to approve legislation to limit cost-sharing for insulin under private health insurance and Medicare. The organisation noted that the average net cost of these insulin products is 20% lower than in 2007.

Insurance 130
article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD. Without insurance, brand-name Vyvanse can cost between $500 to $600 per month, depending on the strength. All amphetamine-derived ADHD medications belong to this schedule of drugs. Vyvanse was initially approved by the U.S.

Dosage 92
article thumbnail

Is Adderall a controlled substance?

The Checkup by Singlecare

In 2007, the DEA changed regulations to allow up to 90 days of a schedule II controlled substance to be written at a time. Your state may have more stringent laws, and your insurance carrier may dictate how many they will cover per fill. It is important to be aware of all of these aspects and work with your prescriber.